Cyclooxygenase-1 and -2 isoenzymes

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 5, 1999, Pages 551-557

  Hla, Timothy ^a   Bishop Bailey, D ^a   Liu, C H ^a   Schaefers, H J ^a   Trifan, O C ^a  

^a Department of Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME PURIFICATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SEMINAL VESICLE; SHEEP; SIGNAL TRANSDUCTION;

EID: 0032922594     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00152-6     Document Type: Short Survey

References (43)

1. Bailey J.M., Muza B., Hla T., Salata K. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor. J Lipid Res. 26:(1):1985;54-61.
2. Whiteley P.J., Needleman P. Mechanism of enhanced fibroblast arachidonic acid metabolism by mononuclear cell factor. J Clin Invest. 74:(6):1984;53-2249.
3. Smith W.L., Dewitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 62:(167):1996;167-215.
4. Van der Ouderaa Fj, Buiytenhek M., Nugteren D.H., Van D.D. Purification and characterization of prostaglandin endoperoxide synthetase from sheep vesicular glands. Biochim Biophys Acta. 487:(2):1977;31-315.
5. Hla T., Farrell M., Kumar A., Bailey J.M. Isolation of the cDNA for human prostaglandin H synthase. Prostaglandins. 32:(6):1986;45-829.
6. DeWitt D.L., Smith W.L. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA. 85:(5):1988;6-1412.
7. Merlie J.P., Fagan D., Mudd J., Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem. 263:(8):1988;3-3550.
8. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 88:(7):1991;6-2692.
9. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 266:(29):1991;72-12866.
10. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA. 89:(16):1992;8-7384.
11. Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 268:(12):1993;54-9049.
12. Picot D., Loll P.J., Garavito R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367:(6460):1994;9-243.
13. Kurumbail R.G., Stevens A.M., Gierse J.K., McDonald J.J., Stegeman R.A., Pak J.Y., Gildehaus D., Miyashiro J.M., Penning T.D., Seibert K., Isakson P.C., Stallings W.C. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 384:(6610):1996;8-644.
14. Hla T., Ristimaki A., Appleby S., Barriocanal J.G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci. 696:(197):1993;197-204.
15. Kraemer S.A., Meade E.A., DeWitt D.L. Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch Biochem Biophys. 293:(2):1992;391-400.
16. S.B. Appleby, A. Ristimaki, K. Neilson, K. Narko, T. Hla, Structure of the human cyclo-oxygenase-2 gene, Biochem J (1994) 723-7.
17. Ristimaki A., Garfinkel S., Wessendorf J., Maciag T., Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem. 269:(16):1994;75-11769.
18. A. Ristimaki, K. Narko, T. Hla, Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation, Biochem J (1996) 325-31.
19. Gou Q., Liu C.H., Ben-Av P., Hla T. Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3′-untranslated region. Biochem Biophys Res Commun. 242:(3):1998;12-508.
20. Schuster V.L. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol. 60:(221):1998;42-221.
21. Serhan C.N. Cell-cell interactions in the generation of eicosanoids: charting the routes and products of transcellular biosynthesis. J Lab Clin Med. 121:(3):1993;4-372.
22. Eguchi Y., Eguchi N., Oda H., Seiki K., Kijima Y., Matsu uY, Urade Y., Hayaishi O. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA. 94:(26):1997;94-14689.
23. Narumiya S. Prostanoid receptors and signal transduction. Prog Brain Res. 113:(231):1996;41-231.
24. Ziche M., Jones J., Gullino P.M. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst. 69:(2):1982;82-475.
25. Sano H., Hla T., Maier J.A., Crofford L.J., Case J.P., Maciag T., Wilder R.L. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest. 89:(1):1992;97-108.
26. Ben-Av P., Crofford L.J., Wilder R.L., Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. Febs Lett. 372:(1):1995;7-83.
27. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83:(5):1995;9-813.
28. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol. 12:(335):1996;63-335.
29. Santoro M.G., Benedetto A., Carruba G., Garaci E., Jaffe B.M. Prostaglandin A compounds as antiviral agents. Science. 209:(4460):1980;4-1032.
30. Negishi M., Koizumi T., Ichikawa A. Biological actions of delta 12-prostaglandin J2. J Lipid Mediat Cell Signal. 12:(23):1995;8-443.
31. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:(2):1998;52-241.
32. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:(6662):1998;6-82.
33. Ohki S., Ogino N., Yamamoto S., Hayaishi O. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem. 254:(3):1979;36-829.
34. Munroe D.G., Wang E.Y., MacIntyre J.P., Tam S.S., Lee D.H., Taylor G.R., Zhou L., Plante R.K., Kazami S.M., Bauerle P.A., et al. Novel intracellular signaling function of prostaglandin H synthase-1 in NF-kappa B activation. J Inflamm. 45:(4):1995;8-260.
35. Josephy P.D., Eling T.E., Mason R.P. Co-oxidation of benzidine by prostaglandin synthase and comparison with the action of horseradish peroxidase. J Biol Chem. 258:(9):1983;9-5561.
36. Narko K., Ristimaki A., MacPhee M., Smith E., Haudenschild C.C., Hla T. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J Biol Chem. 272:(34):1997;60-21455.
37. Crofford L.J., Wilder R.L., Ristimaki A.P., Sano H., Remmers E.F., Epps H.R., Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest. 93:(3):1994;101-1095.
38. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., Dubois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:(4):1994;8-1183.
39. San H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:(17):1995;9-3785.
40. Hwang D., Scollard D., Byrne J., Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 90:(6):1998;60-455.
41. Hida T., Leyton J., Makheja A.N., Ben A.P., Hla T., Martinez A., Mulshine J., Malkani S., Chung P., Moody T.W. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res. 18:(2A):1998;82-775.
42. Greenberg E.R., Baron J.A. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents. Iarc Sci Publ. 1996:(139):1996;8-91.
43. Tsuji M., Dubois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995. 83:(3):1996;493-501.